Japan approves Biomerica's 10-minute PSA (prostate specific antigen) test:
This article was originally published in Clinica
Executive Summary
The Japanese Ministry of Health has approved for sale Biomerica's 10-minute, disposable prostate specific antigen (PSA) test for prostate cancer screening. The EZ-PSA is an easy-to-use, one-step, finger-prick-based blood test for use in a doctor's office. It indicates whether a patient has an elevated level of PSA, which can provide an early marker for the disease. "We are very optimistic about this market because the incidence of prostate cancer in Japan has been on the rise over the past 10 years" says Francis Capitanio, president of the Newport Beach, California, company.
You may also be interested in...
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.